Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Paris - Delayed Quote EUR

Boiron SA (BOI.PA)

Compare
25.20
+0.25
+(1.00%)
At close: February 21 at 5:35:05 PM GMT+1
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
493,248
493,248
534,239
455,201
513,582
Cost of Revenue
135,165
135,165
154,513
127,579
118,841
Gross Profit
358,083
358,083
379,726
327,622
394,741
Operating Expense
317,273
317,273
323,099
288,080
325,011
Operating Income
40,810
40,810
56,627
39,542
69,730
Net Non Operating Interest Income Expense
2,198
2,198
-722
789
-1,146
Pretax Income
46,851
46,851
59,199
46,113
37,217
Tax Provision
12,911
12,911
14,919
17,554
11,008
Net Income Common Stockholders
35,827
35,827
44,673
28,556
26,209
Diluted NI Available to Com Stockholders
35,827
35,827
44,673
28,556
26,209
Basic EPS
2.06
2.06
2.57
1.63
1.50
Diluted EPS
2.06
2.06
2.57
1.63
1.50
Basic Average Shares
17,362.22
17,362.22
17,389.17
17,516.47
17,508.15
Diluted Average Shares
17,362.22
17,362.22
17,389.17
17,516.47
17,508.15
Total Operating Income as Reported
42,290
42,290
63,448
46,842
38,185
Total Expenses
452,438
452,438
477,612
415,659
443,852
Net Income from Continuing & Discontinued Operation
35,827
35,827
44,673
28,556
26,209
Normalized Income
37,172.25
37,172.25
46,453.01
25,396.62
46,719.34
Interest Income
7,462
7,462
1,817
590
459
Interest Expense
1,191
1,191
607
359
348
Net Interest Income
2,198
2,198
-722
789
-1,146
EBIT
48,042
48,042
59,806
46,472
37,565
EBITDA
73,667
73,667
77,020
64,596
106,820
Reconciled Cost of Revenue
135,165
135,165
154,513
127,579
118,841
Reconciled Depreciation
25,625
25,625
17,214
18,124
69,255
Net Income from Continuing Operation Net Minority Interest
35,827
35,827
44,673
28,556
26,209
Total Unusual Items Excluding Goodwill
4,077
4,077
3,004
5,104
-29,134
Total Unusual Items
8,374
8,374
7,031
5,104
-29,134
Normalized EBITDA
65,293
65,293
69,989
59,492
135,954
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
1,125.25
1,125.25
757.01
1,944.62
-8,623.66
12/31/2020 - 1/3/1991

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

EVT.VI Evotec SE
8.50
-0.82%
 
PLCN.CN Cannibble Food-Tech Ltd.
0.0200
-33.33%
 
N4P.L N4 Pharma Plc
0.5750
0.00%
 
TEV.F Teva Pharmaceutical Industries Limited
16.10
-2.13%
 
3320.HK China Resources Pharmaceutical Group Limited
5.480
+1.29%
 
RJF.MC Laboratorio Reig Jofre, S.A.
2.6900
+1.13%
 
APH.L Alliance Pharma plc
60.80
+0.33%
 
DICOT.ST Dicot Pharma AB
0.2655
+1.53%
 
HLUN-A.CO H. Lundbeck A/S
32.95
+1.07%
 
PHO.OL Photocure ASA
51.50
-0.39%